Home › Squamous Cell Carcinoma › Washington
Squamous Cell Carcinoma clinical trials in Washington, DC
4 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RecruitingPhase 3
- George Washington University Cancer Center, Washington D.C.
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- The George Washington University, Washington D.C.
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA10 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- Nashville, TN7 studies
- Houston, TX7 studies
- New York City, NY7 studies
- Atlanta, GA5 studies
- Arlington, VA4 studies
- Durham, NC4 studies
- Orlando, FL4 studies
- Tampa, FL4 studies
- Queens, NY4 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.